CEO ของ Revolution Medicines นาย Goldsmith ขายหุ้นมูลค่า 18 ล้านดอลลาร์ โดย Investing.com

Revolution Medicines Raises $500 Million via Convertible Notes

Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Revolution Medicines Announces Public Offering of Common Stock and Convertible Notes, Details Underwriting Agreement and Lock-Up Provisions

Revolution Medicines (RVMD) director exercises 120K options, sells 120K shares under 10b5-1 plan

HC Wainwright Issues Pessimistic Estimate for RVMD Earnings